Renaissance Technologies LLC Invests $1.47 Million in UroGen Pharma Ltd. (NASDAQ:URGN)
Renaissance Technologies LLC purchased a new stake in UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 138,200 shares of the company’s stock, valued at approximately $1,472,000. Several other institutional investors and hedge funds have also bought and sold shares of URGN. Rosalind Advisors Inc. bought a new […]
More Stories
UAE Halts All Iranian Trade After 2 Missiles Launched From Iranian Territory
By Jill McLaughlin The United Arab Emirates (UAE) halted all trade with Iran after officials determined two missiles detected earlier...
Amazon to Expand Drone Deliveries to Nearly 500 US Cities
By Bill Pan Amazon is expanding its airborne delivery service, with a goal of using drones to deliver small packages...
US Gas Prices on the Rise, Diesel Sees Higher Increase
By Jack Phillips Gas and diesel prices are rising again, according to new data, amid uncertainty over the conflict in...
Trump Says He Brokered ‘Very Good Deal’ With Ottawa, Including Lowered Tariffs on Canada
By Matthew Horwood U.S. President Donald Trump says a preliminary trade deal made with Canada will benefit both countries, including...
How to Generate High-Authority Backlinks? Proven Strategies to Increase Organic Traffic
Creating attractive and useful content is a smart part of SEO. If websites with higher authority and credibility do not...
Health Officials Report More Cases of Flesh-Eating Beach Bacteria
By Jack Phillips Health officials have reported that cases of a rare type of flesh-eating bacteria found in warm seawater...